1. Home
  2. ADVB vs EVGN Comparison

ADVB vs EVGN Comparison

Compare ADVB & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ADVB

Advanced Biomed Inc.

HOLD

Current Price

$0.26

Market Cap

8.4M

Sector

Health Care

ML Signal

HOLD

Logo Evogene Ltd

EVGN

Evogene Ltd

HOLD

Current Price

$1.16

Market Cap

9.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADVB
EVGN
Founded
2014
1999
Country
United States
Israel
Employees
N/A
75
Industry
Medical Specialities
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
9.1M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
ADVB
EVGN
Price
$0.26
$1.16
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.50
AVG Volume (30 Days)
38.4K
28.1K
Earning Date
02-18-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$8,016,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.19
52 Week Low
$0.25
$0.93
52 Week High
$4.10
$2.42

Technical Indicators

Market Signals
Indicator
ADVB
EVGN
Relative Strength Index (RSI) 35.78 62.90
Support Level $0.25 $0.99
Resistance Level $0.35 $1.10
Average True Range (ATR) 0.03 0.06
MACD -0.00 0.01
Stochastic Oscillator 12.17 69.22

Price Performance

Historical Comparison
ADVB
EVGN

About ADVB Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.

Share on Social Networks: